NanoViricides
NNVC
#10132
Rank
โ‚น1.98 B
Marketcap
โ‚น110.50
Share price
0.82%
Change (1 day)
-10.63%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น56.59

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น60.19. In 2024 the company made an earnings per share (EPS) of -โ‚น62.89 an increase over its 2023 EPS that were of -โ‚น66.48.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น56.59-10%
2024-โ‚น62.89-5.41%
2023-โ‚น66.485.71%
2022-โ‚น62.89-13.58%
2021-โ‚น72.77-66.11%
2020-โ‚น214.711.7%
2019-โ‚น211.12-10.98%
2018-โ‚น237.17-22.35%
2017-โ‚น305.44-10.53%
2016-โ‚น341.38375%
2015-โ‚น71.87-85.19%
2014-โ‚น485.1242.11%
2013-โ‚น341.3826.67%
2012-โ‚น269.51-6.25%
2011-โ‚น287.4714.28%
2010-โ‚น251.54100%
2009-โ‚น125.77-0%
2008-โ‚น125.77-33.33%
2007-โ‚น188.66-0%
2006-โ‚น188.664445.07%
2005-โ‚น4.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.49-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น190.45-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น585.73-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น266.81-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น682.20-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น323.05-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK